表皮生长因子受体的单克隆抗体与肿瘤
摘要
表皮生长因子受体是一类细胞信号转导的重要因素,其过度表达已被证明与某些肿瘤存在密切联系。以表皮生长因子受体为作用靶点的单克隆抗体是抗肿瘤治疗中的一个新思路。
出处
《海军总医院学报》
2006年第3期164-166,共3页
Journal of Naval General Hospital of PLA
参考文献14
-
1Ryan PD,Chabner BA.On receptor inhibitors and chemotherapy[J].Chin Cancer Res,2000,6(12):4607-4609.
-
2Klohs WD,Fry DW,Kraker AJ.Inhibitors of tyrosine kinase[J].Curr Opin Oncol,1997,9(6):562-568.
-
3Heldin CH,Ostman A,Ronnstrand L.Signal transduction via platelet-derived growth factor receptors[J].Biochim Biophys Acta,1998,1378(1):F79-F113.
-
4Mendelson J,Baselga J.Status of epidermal growth factor receptor antagonist in the biology and treatment of cancer[J].J Clin Oncol,2003,21(14):2787-2799.
-
5范建华,赵建阳,成国祥.EGFR单抗与肿瘤治疗进展[J].中国肿瘤生物治疗杂志,2003,10(3):221-222. 被引量：3
-
6Kawamoto T,Sato JD,Le A,et al.Growth stimulation of A431 cells by epidermal growth factor:identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody[J].Proc Natl Acad Sci USA,1983,80(5):1337-1341.
-
7Baselga J,Pfister D,Cooper MR,et al.Phase Ⅰ studiesof anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin[J].J Clin Oncol,2000,18(4):904-914.
-
8代志军,王西京,刘小旭.抗EGFR单克隆抗体cetuximab的研究进展[J].中国肿瘤生物治疗杂志,2003,10(1):63-65. 被引量：7
-
9Harding J,Burtness B.Cetuximab:an epidermal growth factor receptor chemeric human-murine monoclonal antibody[J].Drugs Today(Barc),2005,41(2):107-127.
-
10Rowinsky EK,Schwartz GH,Gollob JA,et al.Safety,pharmacokinetics.and activity of ABX-EGF,a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer[J].J Clin Oncol,2004,22(15):3003-3015.
二级参考文献35
-
1[1]Kawamoto TK, Sato JD, Le A, et al. Growth stimulation of A431 cells by epidermal growth factor: Identification of high-affinity receptors for epidermal grpwth factor by an anti-receptor monoclonal antibody[J]. PNAS, 1983, 80: 1337-1341.
-
2[2]Paul M, Harari PM, Huang SM. Head and neck cancer as a clinical model for molecular targeting of therapy: Combining EGFR blockade with radiation[J]. Int J Radiat Oncol Biol Phys, 2001, 49(2): 427-433.
-
3[3]Perrotte P, Matsumoto T, Inoue K, et al. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinorma growing orthotopically in nude mice[J]. Clin Cancer Res, 1999, (5): 257-265.
-
4[4]Karashima T, Sweeney P, Slaton JW, et al. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice[J]. Clin Cancer Res, 2002, 8(5): 1253-1264.
-
5[5]Wu X, Fan Z, Masui H, et al. Apoptosis induced by an anti-epidermal growth factor receptor antibody in a human colorectal carcinorma cell line and its delay by insulin[J]. J Clin Invest, 1995, 95: 1897-1905.
-
6[6]Huang SM, Bock JM, Harari PM. Epidermal growth factor receptor blockade with C225 modulates proliferation,apoptosis,and radiosensitivity in squamous cell carcinorma of the head and neck[J]. Cancer Res, 1999, 59: 1935-1940.
-
7[7]Tortora G, Caputo R, Pomatico G, et al. Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growth[J]. Clin Cancer Res, 1999, 5: 875-881.
-
8[8]Bruns CJ, Harbison MT, Davis DW, et al. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms[J]. Clin Cancer Res, 2000, 6: 1936-1948.
-
9[9]Aboud-Pirak E, Hurwitz E, Pirak ME, et al. Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice[J]. J Natl Cancer Inst, 1988, 80: 1605-1611.
-
10[10]Baselga J, Norton L, Masui H, et al. Antitumor e.ects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies[J]. J Natl Cancer Inst, 1993, 85: 1327-1333.
共引文献8
-
1邹学,李俊,尹庆春.单克隆抗体药物诱发肿瘤细胞凋亡的研究进展[J].总装备部医学学报,2008(2):115-117.
-
2张娜,贾泽明,张阳德.大肠癌化疗进展[J].中国现代医学杂志,2006,16(15):2311-2313. 被引量：3
-
3谢红建,白咸勇.针对表皮生长因子受体的胃癌导向治疗研究进展[J].滨州医学院学报,2007,30(4):286-287.
-
4孙思凡,张部昌,靳彦文.治疗性单克隆抗体研究进展[J].生物技术通讯,2009,20(2):258-262. 被引量：10
-
5孙思凡,靳彦文,李平,曹诚,张部昌.新型抗EGFR人源化抗体基因的构建和表达[J].军事医学科学院院刊,2009,33(6):526-530. 被引量：1
-
6冉健,孙万邦.乳腺癌免疫生物治疗研究进展[J].国际检验医学杂志,2012,33(2):197-199. 被引量：8
-
7范丽颖,张莹,于源华.高表达单克隆抗体ER的细胞株筛选[J].长春理工大学学报（自然科学版）,2012,35(4):188-191.
-
8潘东升,沈连忠,盖文琳,周晓冰,李波.抗表皮生长因子受体全人单克隆抗体Ranti-HER的抗肿瘤药理作用研究[J].中国药学杂志,2016,51(21):1839-1847. 被引量：2
